Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference

NEXT STORY
Genmab Announces that Janssen has Submitted a Supplemental Biologics License Application to U.S. FDA for use of DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj) in Patients with Light-chain (AL) Amyloidosis
PREV STORY
Immunoscore® to select patients in the POCHI trial, a phase II multicenter trial testing immunotherapy with chemotherapy and bevacizumab in metastatic colorectal cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis

  Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupixent® (dupilumab) showed positive Phase 3 ...

author_avatar
NASDAQ Market News

UPDATE — Foamix Receives FDA Approval of AMZEEQ™ Topical Minocycline Treatment for Millions of Moderate to Severe Acne Sufferers

author_avatar
NASDAQ Market News

Single-Cell Analysis Market in Asia to Witness Fastest Growth by 2022: P&S Market Research

NEW YORK, July 18, 2017 (GLOBE NEWSWIRE) -- According to market research “Global Single-Cell ...

author_avatar
NASDAQ Market News